Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Travere Therapeutics, Inc. (TVTX) had Return on Equity of -37.07% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$127.20M |
|
$-37.10M |
|
$1.95M |
|
$125.25M |
|
$164.11M |
|
$-36.91M |
|
$0.19M |
|
$-36.72M |
|
$-36.72M |
|
$-36.60M |
|
$-36.60M |
|
$-37.10M |
|
$-36.60M |
|
$-36.91M |
|
$-11.70M |
|
91.87M |
|
91.87M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$392.68M |
|
$3.63M |
|
$162.51M |
|
$555.19M |
|
$125.44M |
|
$312.08M |
|
$331.02M |
|
$456.46M |
|
$98.73M |
|
$-11.31M |
|
$98.73M |
|
92.40M |
|
| Cash Flow Statement Financials | |
$-40.37M |
|
$21.55M |
|
$4.20M |
|
$93.03M |
|
$78.36M |
|
$-14.67M |
|
$16.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
0.76 |
|
3.16 |
|
98.47% |
|
-29.02% |
|
-29.02% |
|
-- |
|
-28.87% |
|
-29.17% |
|
$-40.37M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.31 |
|
1.46 |
|
61.77 |
|
|
Return on Equity |
-37.07% |
323.62% |
|
-6.59% |
|
-8.91% |
|
$1.07 |
|
$-0.44 |
|
$-0.44 |
|